⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Rash maculo-papular

8,238 total reports4.9% serious outcomes

8,238

Total Reports

Deaths

385

Hospitalizations

4.9

Severity Rate

% serious outcomes

About Rash maculo-papular Reports

Rash maculo-papular has been reported 8,238 times in VAERS from 1990 to 2026.

Of these reports, 19 were associated with death (0.23%) and 385 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Rash maculo-papular is 4.9%.

Understanding Rash maculo-papular in VAERS

•Temporal association only: These reports show Rash maculo-papular occurred after vaccination, not necessarily because of vaccination.

•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.

•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.

•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Rash maculo-papular. This may reflect usage patterns, not causation.

Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.

Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.